Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model

Biochemical Society Transactions

Volumn 38, Issue 4, 2010, Pages 1001-1005

  Ando, Kunie ^a   Leroy, Karelle ^a   Heraud, Céline ^a   Kabova, Anna ^a   Yilmaz, Zehra ^a   Authelet, Michèle ^a   Suain, Valèrie ^a   De Decker, Robert ^a   Brion, Jean Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alzheimer's disease; Neurofibrillary tangle (NFT); Paired helical filament tau (PHF tau); Tau; Tau knockout; Tau transgenic mouse

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN; CROSSING OVER; GENE DELETION; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TAUOPATHY;

ALZHEIMER DISEASE; ANIMALS; CHEMICAL PRECIPITATION; DISEASE MODELS, ANIMAL; GENE DELETION; HUMANS; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; PROTEIN MULTIMERIZATION; TAU PROTEINS; TAUOPATHIES; UP-REGULATION;

MURINAE; MUS; MUS MUSCULUS;

EID: 77955938694     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0381001     Document Type: Review

References (48)

1. Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms: phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33, 95-130
2. Caceres, A. and Kosik, K.S. (1990) Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 343, 461-463
3. Harada, A., Oguchi, K., Okabe, S., Kuno, J., Terada, S., Ohshima, T., Sato-Yoshitake, R., Takei, Y., Noda, T. and Hirokawa, N. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369, 488-491
4. Dawson, H.N., Ferreira, A., Eyster, M.V., Ghoshal, N., Binder, L.I. and Vitek, M.P. (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell Sci. 114, 1179-1187
5. Tucker, K.L., Meyer, M. and Barde, Y.A. (2001) Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4, 29-37
6. Ikegami, S., Harada, A. and Hirokawa, N. (2000) Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci. Lett. 279, 129-132
7. Ding, H., Dolan, P.J. and Johnson, G.V. (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J. Neurochem. 106, 2119-2130
8. Perez, M., Santa-Maria, I., de Barreda, E.G., Zhu, X.W., Cuadros, R., Cabrero, J.R., Sanchez-Madrid, F., Dawson, H.N., Vitek, M.P., Perry, G. et al. (2009) Tau: an inhibitor of deacetylase HDAC6 function. J. Neurochem. 109, 1756-1766
9. Hong, X.P., Peng, C.X., Wei, W., Tian, Q., Liu, Y.H., Yao, X.Q., Zhang, Y., Cao, F.Y., Wang, Q. and Wang, J.Z. (2009) Essential role of tau phosphorylation in adult hippocampal neurogenesis. Hippocampus, doi:10.1002/hipo.20712
10. van Swieten, J. and Spillantini, M.G. (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 17, 63-73
11. Denk, F. and Wade-Martins, R. (2009) Knock-out and transgenic mouse models of tauopathies. Neurobiol. Aging 30, 1-13
12. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. and LaFerla, F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421
13. Perez, M., Ribe, E., Rubio, A., Lim, F., Moran, M.A., Ramos, P.G., Ferrer, I., Isla, M.T. and Avila, J. (2005) Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience 130, 339-347
14. Terwel, D., Muyllaert, D., Dewachter, I., Borghgraef, P., Croes, S., Devijver, H. and Van Leuven, F. (2008) Amyloid activates GSK-3β to aggravate neuronal tauopathy in bigenic mice. Am. J. Pathol. 172, 786-798
15. Schindowski, K., Bretteville, A., Leroy, K., Begard, S., Brion, J.P., Hamdane, M. and Buée, L. (2006) Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am. J. Pathol. 169, 599-616
16. Leroy, K., Bretteville, A., Schindowski, K., Gilissen, E., Authelet, M., De Decker, R., Yilmaz, Z., Buée, L. and Brion, J.P. (2007) Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am. J. Pathol. 171, 976-992
17. Brion, J.P., Tremp, G. and Octave, J.N. (1999) Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer disease. Am. J. Pathol. 154, 255-270
18. Götz, J., Probst, A., Spillantini, M.G., Schäfer, T., Jakes, R., Bürki, K. and Goedert, M. (1995) Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 14, 1304-1313
19. Higuchi, M., Ishihara, T., Zhang, B., Hong, M., Andreadis, A., Trojanowski, J.Q. and Lee, V.M.Y. (2002) Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35, 433-446
20. Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M.K., Trojanowski, J.Q. and Lee, V.M.Y. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762
21. Ishihara, T., Zhang, B., Higuchi, M., Yoshiyama, Y., Trojanowski, J.Q. and Lee, V.M.Y. (2001) Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am. J. Pathol. 158, 555-562
22. Probst, A., Götz, J., Wiederhold, K.H., Tolnay, M., Mistl, C., Jaton, A.L., Hong, M., Ishihara, T., Lee, V.M.Y., Trojanowski, J.Q. et al. (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 99, 469-481
23. Duff, K., Knight, H., Refolo, L.M., Sanders, S., Yu, X., Picciano, M., Malester, B., Hutton, M., Adamson, J., Goedert, M. et al. (2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis. 7, 87-98
24. Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K.L., Barde, Y.A., Duff, K. and Davies, P. (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem. 86, 582-590
25. Andorfer, C., Acker, C.M., Kress, Y., Hof, P.R., Duff, K. and Davies, P. (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 25, 5446-5454
26. Terwel, D., Lasrado, R., Snauwaert, J., Vandeweert, E., Van Haesendonck, C., Borghgraef, P. and Van Leuven, F. (2005) Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice. J. Biol. Chem. 280, 3963-3973
27. Allen, B., Ingram, E., Takao, M., Smith, M.J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P.C. et al. (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340-9351
28. Clavaguera, F., Bolmont, T., Crowther, R.A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A.K., Beibel, M., Staufenbiel, M. et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913
29. Kampers, T., Pangalos, M., Geerts, H., Wiech, H. and Mandelkow, E. (1999) Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS Lett. 451, 39-44
30. Pevalova, M., Filipcik, P., Novak, M., Avila, J. and Iqbal, K. (2006) Post-translational modifications of tau protein. Bratisl. Lek. Listy 107, 346-353
31. Hanger, D.P., Anderton, B.H. and Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112-119
32. Greenwood, J.A., Scott, C.W., Spreen, R.C., Caputo, C.B. and Johnson, G.V.W. (1994) Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert: identification of threonine 39 as the primary phosphate acceptor. J. Biol. Chem. 269, 4373-4380
33. Hanger, D.P., Byers, H.L., Wray, S., Leung, K.Y., Saxton, M.J., Seereeram, A., Reynolds, C.H., Ward, M.A. and Anderton, B.H. (2007) Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 282, 23645-23654
34. Saitoh, T. and Iimoto, D. (1989) Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease. Prog. Clin. Biol. Res. 317, 769-780
35. Lee, G., Thangavel, R., Sharma, V.M., Litersky, J.M., Bhaskar, K., Fang, S.M., Do, L.H., Andreadis, A., Van Hoesen, G. and Ksiezak-Reding, H. (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24, 2304-2312
36. 50 promotes microtubule assembly. J. Cell Sci. 118, 397-408
37. Mandelkow, E.M., Schweers, O., Drewes, G., Biernat, J., Gustke, N., Trinczek, B. and Mandelkow, E. (1996) Structure, microtubule interactions, and phosphorylation of tau protein. Ann. N.Y. Acad. Sci. 777, 96-106
38. Carmel, G., Mager, E.M., Binder, L.I. and Kuret, J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789-32795
39. Jicha, G.A., Bowser, R., Kazam, I.G. and Davies, P. (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128-132
40. Binder, L.I., Guillozet-Bongaarts, A.L., Garcia-Sierra, F. and Berry, R.W. (2005) Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 1739, 216-223
41. Weaver, C.L., Espinoza, M., Kress, Y. and Davies, P. (2000) Conformational change as one of the earliest alterations of tan in Alzheimer's disease. Neurobiol. Aging 21, 719-727
42. Selkoe, D.J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498
43. Hardy, J.A. and Higgins, G.A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185
44. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356
45. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F. et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527
46. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F.S. and Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102
47. Sw mice. Neurosci. Lett. 299, 169-172
48. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P.A. et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292